Insider · CIK 0001814338
Diem Nguyen
ceoofficerdirector
Files at SIGA (SIGA TECHNOLOGIES INC), VRCA (Verrica Pharmaceuticals Inc.), CADL (Candel Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | CADL Candel Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +14,240 | $0.00 | $0 | 14,240 | Jun 18, 2025 |
| Jun 5, 2025 | VRCA Verrica Pharmaceuticals Inc. | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 9, 2025 |
| Oct 25, 2024 | SIGA SIGA TECHNOLOGIES INC | MOption exercise Common Stock, par value $.0001 per share | +59,288 | $0.00 | $0 | 59,288 | Oct 29, 2024 |
| Oct 25, 2024 | SIGA SIGA TECHNOLOGIES INC | FTax withholding Common Stock, par value $.0001 per share | -23,893 | $6.77 | $162k | 35,395 | Oct 29, 2024 |
| Oct 25, 2024 | SIGA SIGA TECHNOLOGIES INC | MOption exercise Performance Stock Unitsderivative | -59,288 | $0.00 | $0 | 118,577 | Oct 29, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.